Bixiye
QP104-21 Colorectal Cancer: Screening Age Range Update
Taariikhda uu dhaqangalayo Barnaamijka: Des 22, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2031 - 2040 ee natiijooyinka 3167
Bixiye
QP99-21 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP100-21 Checks to be Sent for Unpaid Prompt Pay Penalties
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP96-21 Processing Change for HCPCS Code A9279
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021
Bixiye
2021 December Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: Des 03, 2021
Bixiye
P68R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021